| |
| |
|
| Insider
Information: |
Mcgraw Benjamin F III |
| Relationship: |
Director |
| City: |
Irvine |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
42,215 |
|
|
Indirect Shares
|
10,909 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
53,124 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
ISTA Pharmaceuticals Inc |
ISTA |
Director |
2012-06-06 |
0 |
2004-10-20 |
0 |
Premium* |
|
|
Urigen Pharmaceuticals |
URGP |
COB, President and CEO... |
2007-06-30 |
42,215 |
2007-06-30 |
10,909 |
Premium* |
|
|
Aerie Pharmaceuticals Inc |
AERI |
Director |
2022-11-21 |
0 |
2015-04-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AERI |
Aerie Pharmaceuticals Inc |
Director |
– • – |
2022-11-21 |
4 |
D |
$15.25 |
$640,256 |
D/D |
(41,984) |
0 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Director |
– • – |
2022-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
6,245 |
41,984 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Interim Executive Chair |
• • – |
2022-02-28 |
4 |
D |
$8.30 |
$85,689 |
D/D |
(10,324) |
35,739 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Interim Executive Chair |
• • – |
2021-09-20 |
4 |
A |
$0.00 |
$0 |
D/D |
34,513 |
46,063 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Director |
– • – |
2021-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
1,750 |
11,550 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Director |
– • – |
2020-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,750 |
9,800 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Director |
– • – |
2019-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
1,750 |
8,050 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Director |
– • – |
2018-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,750 |
6,300 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Director |
– • – |
2017-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
1,150 |
4,550 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Director |
– • – |
2016-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
1,700 |
3,400 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Director |
– • – |
2015-04-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,700 |
1,700 |
0 |
- |
|
| ISTA |
ISTA Pharmaceuticals Inc |
Director |
– • – |
2012-06-06 |
4 |
D |
$9.10 |
$58,531 |
D/D |
(6,432) |
0 |
0 |
- |
|
| ISTA |
ISTA Pharmaceuticals Inc |
Director |
– • – |
2008-12-10 |
4 |
A |
$0.00 |
$2 |
D/D |
2,466 |
7,932 |
0 |
- |
|
| ISTA |
ISTA Pharmaceuticals Inc |
Director |
– • – |
2007-10-11 |
4 |
A |
$0.00 |
$2 |
D/D |
2,466 |
5,466 |
0 |
- |
|
| URGP |
Urigen Pharmaceuticals |
COB, President and CEO |
• • – |
2007-06-30 |
4 |
D |
$0.16 |
$283 |
D/D |
(1,771) |
42,215 |
0 |
- |
|
| URGP |
Urigen Pharmaceuticals |
COB, President and CEO |
• • – |
2007-04-30 |
4 |
D |
$0.26 |
$691 |
D/D |
(2,657) |
43,986 |
0 |
- |
|
| URGP |
Urigen Pharmaceuticals |
COB, President and CEO |
• • – |
2007-01-31 |
4 |
D |
$0.26 |
$822 |
D/D |
(3,162) |
46,643 |
0 |
- |
|
| URGP |
Urigen Pharmaceuticals |
COB, President and CEO |
• • – |
2006-10-31 |
4 |
D |
$0.61 |
$1,621 |
D/D |
(2,657) |
49,805 |
0 |
- |
|
| URGP |
Urigen Pharmaceuticals |
COB, President and CEO |
• • – |
2006-07-31 |
4 |
D |
$0.40 |
$1,063 |
D/D |
(2,657) |
52,462 |
|
- |
|
| URGP |
Urigen Pharmaceuticals |
COB, President and CEO |
• • – |
2006-04-30 |
4 |
D |
$3.70 |
$9,831 |
D/D |
(2,657) |
55,119 |
|
- |
|
| URGP |
Urigen Pharmaceuticals |
officerTitle |
• • – |
2006-01-31 |
4 |
D |
$3.16 |
$10,039 |
D/D |
(3,177) |
57,776 |
|
- |
|
| URGP |
Urigen Pharmaceuticals |
COB, President and CEO |
• • – |
2005-10-31 |
4 |
D |
$2.40 |
$6,377 |
D/D |
(2,657) |
60,953 |
|
- |
|
| URGP |
Urigen Pharmaceuticals |
COB, President and CEO |
• • – |
2005-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
59,464 |
63,610 |
|
- |
|
| ISTA |
ISTA Pharmaceuticals Inc |
Director |
– • – |
2004-10-20 |
4 |
A |
$0.00 |
$2 |
D/D |
1,500 |
3,000 |
0 |
- |
|
| ISTA |
ISTA Pharmaceuticals Inc |
Director |
– • – |
2004-10-20 |
4 |
A |
$0.00 |
$2 |
D/D |
1,500 |
1,500 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
